EPI2018-02-19T13:46:34+00:00

Project Description

Epigenomics AG (EPI)

EPI

Epigenomics will leverage existing bisulfite, DNA methylation marker and NGS technology to develop an innovative product prototype within WP7. EPI will develop a multi marker NGS assay for relevant DNA-methylation markers identified in COLOSSUS, accompanied by a suitable set of controls/standards, additional markers for total DNA and/or tumour DNA, and an optimized pre-analytic for fast and automatable library preparation.

Partner Details

EPIGENOMICS AG, (EPI)

Kleine Praesidentenstr 1,
Berlin 10178,
Germany.

Dr Joern Lewin